Panama - engelska - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

laboratorios normon, s.a. - losartan potasico - losartan potasico....50.0 mg

Panama - engelska - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

corporaciÓn bonima, s.a. de c.v. - losartan potasico - losartan potasico....50.00 mg / hidroclorotiazida....12.50 mg

Panama - engelska - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

corporaciÓn bonima, s.a. de c.v. - losartan potasico - losartan potasico....100.000mg / hidroclorotiazida....25.000mg

Panama - engelska - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

laboratorios cinfa, s.a. - losartan potasico - losartan potasico....50 mg

Panama - engelska - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

laboratorios ecar s.a. - losartÁn (potÁsico) - losartÁn (potÁsico)....50.00 mg / hidroclorotiazida....12.5 mg

USA - engelska - NLM (National Library of Medicine)

state of florida doh central pharmacy - losartan potassium (unii: 3st302b24a) (losartan - unii:jms50mpo89) - losartan potassium 25 mg - hypertension losartan potassium tablets are indicated for the treatment of hypertension. it may be used alone or in combination with other antihypertensive agents, including diuretics.   hypertensive patients with left ventricular hypertrophy losartan potassium tablets are indicated to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy, but there is evidence that this benefit does not apply to black patients (see precautions, race and clinical pharmacology, pharmacodynamics and clinical effects, reduction in the risk of stroke, race ). nephropathy in type 2 diabetic patients losartan potassium tablets are indicated for the treatment of diabetic nephropathy with an elevated serum creatinine and proteinuria (urinary albumin to creatinine ratio ≥300 mg/g) in patients with type 2 diabetes and a history of hypertension. in this population, losartan potassium tablets reduces the rate of progression of nephropathy as measured by the occurrence of doubling of

USA - engelska - NLM (National Library of Medicine)

state of florida doh central pharmacy - losartan potassium (unii: 3st302b24a) (losartan - unii:jms50mpo89) - losartan potassium 50 mg - hypertension losartan potassium tablets are indicated for the treatment of hypertension. it may be used alone or in combination with other antihypertensive agents, including diuretics. hypertensive patients with left ventricular hypertrophy losartan potassium tablets are indicated to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy, but there is evidence that this benefit does not apply to black patients. (see precautions, race and clinical pharmacology, pharmacodynamics and clinical effects, reduction in the risk of stroke, race.) nephropathy in type 2 diabetic patients losartan potassium tablets are indicated for the treatment of diabetic nephropathy with an elevated serum creatinine and proteinuria (urinary albumin to creatinine ratio ≥300 mg/g) in patients with type 2 diabetes and a history of hypertension. in this population, losartan potassium tablets reduce the rate of progression of nephropathy as measured by the occurrence of doubling of serum creatinine or end

USA - engelska - NLM (National Library of Medicine)

direct rx - losartan potassium (unii: 3st302b24a) (losartan - unii:jms50mpo89) - losartan potassium 50 mg - - hypertension losartan potassium tablets are indicated for the treatment of hypertension. it may be used alone or in combination with other antihypertensive agents, including diuretics. hypertensive patients with left ventricular hypertrophy losartan potassium tablets are indicated to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy, but there is evidence that this benefit does not apply to black patients. (see precautions, race and clinical pharmacology, pharmacodynamics and clinical effects, reduction in the risk of stroke, race.) nephropathy in type 2 diabetic patients losartan potassium tablets are indicated for the treatment of diabetic nephropathy with an elevated serum creatinine and proteinuria (urinary albumin to creatinine ratio ≥300 mg/g) in patients with type 2 diabetes and a history of hypertension. in this population, losartan potassium tablets reduce the rate of progression of nephropathy as measured by the occurrence of doubling of serum creatinine

USA - engelska - NLM (National Library of Medicine)

readymeds - losartan potassium (unii: 3st302b24a) (losartan - unii:jms50mpo89) - losartan potassium 50 mg - hypertension losartan potassium tablets are indicated for the treatment of hypertension. it may be used alone or in combination with other antihypertensive agents, including diuretics. hypertensive patients with left ventricular hypertrophy losartan potassium tablets are indicated to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy, but there is evidence that this benefit does not apply to black patients (see precautions, race and clinical pharmacology, pharmacodynamics and clinical effects, reduction in the risk of stroke, race ). nephropathy in type 2 diabetic patients losartan potassium tablets are indicated for the treatment of diabetic nephropathy with an elevated serum creatinine and proteinuria (urinary albumin to creatinine ratio ≥300 mg/g) in patients with type 2 diabetes and a history of hypertension. in this population, losartan potassium tablets reduces the rate of progression of nephropathy as measured by the occurrence of doubling of

USA - engelska - NLM (National Library of Medicine)

direct rx - losartan potassium (unii: 3st302b24a) (losartan - unii:jms50mpo89) - losartan potassium 100 mg - hypertension losartan potassium tablets are indicated for the treatment of hypertension. it may be used alone or in combination with other antihypertensive agents, including diuretics. hypertensive patients with left ventricular hypertrophy losartan potassium tablets are indicated to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy, but there is evidence that this benefit does not apply to black patients. (see precautions, race and clinical pharmacology, pharmacodynamics and clinical effects, reduction in the risk of stroke, race.) nephropathy in type 2 diabetic patients losartan potassium tablets are indicated for the treatment of diabetic nephropathy with an elevated serum creatinine and proteinuria (urinary albumin to creatinine ratio ≥300 mg/g) in patients with type 2 diabetes and a history of hypertension. in this population, losartan potassium tablets reduce the rate of progression of nephropathy as measured by the occurrence of doubling of serum creatinine or end